Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A.   Greist John H.   Mallinckrodt Craig H.   Prakash Apurva   Sambunaris Angelo   Tollefson Gary D.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

By Pigott Teresa A.   Prakash Apurva   Arnold Lesley M.   Aaronson Scott T.   Mallinckrodt Craig H.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1303-1318

Informa Healthcare

Access to resources Recommend Favorite

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

By Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1115-1121

Informa Healthcare

Access to resources Recommend Favorite

Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases

By Wang Junling   Liu Xianchen   Mullins C. Daniel  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1303-1313

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

By Ventura Daniel   Armstrong Edward P.   Skrepnek Grant H.   Haim Erder M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 245-250

Informa Healthcare

Access to resources Recommend Favorite